PROVIDER PROFILE · NPI 1013460575
Hussein AdlyM.D.
PRESCRIBING · PART D · 2024
Total Rx claims
1,605
Beneficiaries
—
Total drug cost
$679K
Distinct drugs
25
Brand share
57.0%
Top prescribed drugs
Levothyroxine Sodium238 claims
Empagliflozin135 claims
Dulaglutide126 claims
Metformin Hcl123 claims
Semaglutide106 claims
QUALITY · MIPS · 2024
Final MIPS score
80.0
Quality
58.7
Cost
76.5
Improvement activities
40.0
Promoting interop.
98.0
Payment adjustment
0.21%
Group
CROSS-REFERENCE